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This article reviews the acute and chronic toxicity of the three oxidant air pollutants ozone, nitric oxide (NO), and nitrogen dioxide (NO2). The toxicity
of binary mixtures of NO2 with other inhaled agents is also discussed. Newer studies are emphasized, especially those published in the last 5 years
or still in press. Very recent data from our laboratory that suggest a new cellular mechanism of importance in lung injury in animals exposed to mix-
tures of ozone and NO2 that may have general relevance with regard to the effects of oxidant air pollutants on the lung are also presented.
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Nitric Oxide
Two or three years ago a discussion of the
effects of NO with regard to lung injury
would have been brief and simple.
According to the U.S. EPA's Criteria
Document for NO, (1), "the toxicological
data base for NO is not extensive except
for its interaction with blood [and] ...high
exposure levels are needed [to see] signifi-
cant changes." NO has been estimated to
be about 30 times less toxic than NO2,
based upon pulmonary responses to acute
exposures (1). Since most of the (few)
chronic and subchronic experiments test-
ing the effects ofNO on experimental ani-
mals used atmospheres also containing low
levels ofNO2 (as an impurity arising from
the reaction 2NO+ 02 -e NO2), it is diffi-
cult to interpret these early studies (2,3).
Air quality standards for NO include a
time-weighted average exposure level of25
ppm or less, with a concentration of 100
ppm not to be exceeded for any 15-min
interval. These values should be compared
with the estimated 400 to 1000 ppm of
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NO per puff of cigarette smoke delivered
to the lungs.
However, since this document appeared,
NO has become one ofthe most intensively
studied molecules in recent biology, causing
it to be honored as Science's "Molecule of
the Year" in 1992. What happened? NO,
which arises in the body by the action of
nitric oxide synthetase on its substrate L-
arginine, is a biologically active molecule. It
is apparently identical to the endothelial
cell-derived relaxing factor (EDRF). It also
binds avidly to heme, as in its well-known
reaction with hemoglobin to form methe-
moglobin, with an affinity for hemoglobin
about 1500 times greater than that of car-
bon monoxide (CO). The same avidity for
heme allows it to bind to the heme moiety
of cytosolic guanylate cyclase, stimulating
the formation of cyclic GMP. Via this and
other pathways, NO exerts profound physi-
ologic effects on lung, liver, pancreas,
uterus, peripheral nerves, brain, the immune
system, and especially bloodvessels. NO can
produce localized vasodilation, with
decreased blood pressure, as it diffuses from
arterial endothelial cells that synthesize it to
vascular smooth muscle cells, which respond
by producing additional cGMP. Because of
its high rate of reaction with hemoglobin,
NO does not diffuse far in blood and the
effects of NO on blood vessels only occur
locally over small regions. NO is currently
being evaluated clinically for a possible role
in the treatment ofpulmonary hypertension
in several syndromes, including adult respi-
ratory distress syndrome (ARDS) and persis-
tent pulmonary hypertension of the
newborn (4). It is thought that thevasodila-
tory response ofboth the bronchial and pul-
monary vasculature to cigarette smoke is
directlyattributable to its NO content (5).
Lung cells other than endothelial, such
as alveolar macrophages and fibroblasts, also
can produce NO, and may thus act as effec-
tor cells on smooth muscle and other puta-
tive target cell populations. Interestingly,
synthesis of NO by rat lung fibroblasts is
stimulated by gamma interferon, and this
stimulation is potentiated by lipopolysac-
charide or by interleukin 1p (6).
Ozone
Several recent reviews of the effects of
ozone on the lung have appeared (7-9),
and the reader is referred to these sources
for citations of original research in the
older literature. This review focuses pri-
marily on more recent studies that have
opened new avenues for examination ofthe
effects ofozone on the lung.
The National Ambient Air Quality
Standard (NAAQS) for ozone is a peak
hourly concentration of 0.12 ppm (235
mg/mi3), not to be exceeded twice in one
year. The State of California standard is
0.09 ppm (180 mg/mi). Both standards are
routinely exceeded about half of the days
each year in California's south coast (Los
Angeles) air basin, with Stage 1 smog alerts
(0.20 ppm) common in the summer months.
Mexico City routinely exceeds these levels
essentially every day of the year (estimated
360 days last year). For further details of
ozone occurrence and areas in which stan-
dards are exceeded in the United States, the
reader is referred to the U.S. EPA Air
Quality Criteria Document for Ozone, pub-
lished in updated form in 1994.
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Acute exposure oflaboratory animals to
high concentrations of ozone (2 ppm and
above) causes severe, often fatal, pulmonary
edema (10). Exposure to concentrations of
ozone between about 0.2 ppm (or less) and
1.0 ppm causes effects on the nasal epithe-
lia (11) and on the lung, including mild
edema, inflammation, damage to airway
epithelial cells, and respiratory bronchiolitis
(12-14) at the histologic level. Toxicologic
responses of rats to ozone exposure in this
concentration range include pulmonary
edema, evaluated as increased lung wet
weight or as increased protein content of
lung lavage fluid (15), and increased syn-
thesis rate oflung collagen (16,17).
Chronic exposure of laboratory animals
to concentrations ofozone between 0.2 ppm
(or less) and 1.0 ppm causes sustained respi-
ratory bronchiolitis, extension of terminal
bronchioles into the alveolar zone to form
respiratory bronchioles in rats (a phenome-
non known as bronchiolization), and cen-
triacinar fibrosis (18-21). Based upon recent
studies sponsored by the Health Effects
Institute (HEI) (some yet to be published) of
Fischer 344 rats exposed for 20 months to
0.12 ppm of ozone, bronchiolization may
occur in lungs ofanimals exposed to concen-
trations of ozone at or near the NAAQS
(21). Biochemical studies also have shown
fibrosis in rats and monkeys chronically
exposed to ozone (22-25). Fischer 344 rats
exposed for 20 months (6 hr/day, 5
days/week) to ozone at concentrations of
0.12, 0.5, or 1 ppm show changes in lung
structure. In the rats exposed to 0.5 and 1
ppm ozone, histologically demonstrable pul-
monary fibrosis was also observed (26). We
have since repeated this HEI protocol to per-
form an exposure ofrats for 90 days to either
0.12 or 1 ppm ozone, in an attempt to deter-
mine whether the lesions seen after 20
months were apparent after 90 days. Were
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Figure 1. Hydroxyproline content of right medial lung
lobe from rats exposed for 90 days to filtered air, to
0.12 ppm of ozone, or to 1 ppm of ozone. See Table 1
for details of exposure protocol. Data are presented in
this and all subsequent figures as mean values + 1 SD.
that the case, there is an extensive database
on responses ofrats to ozone exposure over a
90-day period with which these results could
be directly compared. In addition, some
indication ofthe time course ofdevelopment
of the lesions could be inferred, since the
original HEI protocol only allowed for sam-
pling at a single time point, 20 months after
initiation ofexposure.
Biochemical analysis of lungs from the
exposed rats showed no significant changes
in hydroxyproline, a marker for collagen
content (Figure 1). Nor was any change
found in the lung content of hydroxypy-
ridinium, a trifunctional collagen cross-link
known to be increased in lung fibrosis
(Table 1). While histologic and morpho-
metric analysis of these lungs are still in
progress, it is already clear that the rats
exposed to 1 ppm ozone show changes in
their centriacinar region consistent with
bronchiolization, perhaps of comparable
severity to the rats exposed for 20 months.
These observations suggest the relative
insensitivity of total lung hydroxyproline
assays for measuring chronic effects of
ozone exposure on rat lungs, and raise fas-
cinating questions about continued pro-
gression of lung injury with continued
exposure to ozone versus adaptation ofthe
lungs after chronic exposure.
The rate of epithelial cell turnover is
increased in conducting and peripheral air-
ways of animals exposed to ozone (27),
suggesting that ozone might act as a pro-
moter of carcinogenesis in this target cell
population. Small increases in lung tumor
incidence have been reported in Strain A
mice (but not in the Swiss Webster strain)
exposed to ozone (28,29). Thus, based on
these theoretical and experimental argu-
ments, ozone was nominated for testing as
a carcinogen or a co-carcinogen in a
recently completed NIEHS National
Toxicology Program-sponsored bioassay in
rats and mice. The results of these experi-
Table 1. Collagen content of lung lobes from rats
exposed to ozone for 90 days.a
Hydroxypyridinium
Ozone concentration, content of right medial
ppm (nominal) lobe, nmole (n)
0 2.4±0.8(11)
0.12 2.1 ± 0.9(10)
1 2.5±0.8(10)
aFischer 344 rats were exposed to the indicated (nomi-
nal) concentrations of ozone for 6 hr/day (9:00-15:00),
5 days/week. Actual ozone concentrations in the cham-
bers were 0.12 ± 0.02 ppm and 1.00 ± 0.03 ppm. Data
are presented as mean values ± 1 SD with n, the num-
ber ofanimals studied, in parentheses.
ments were released in November 1993
(29) and should allow an estimate of the
extent ofcancer risk (ifany) associated with
inhalation ofozone.
Nitrogen Dioxide
The National Ambient Air Quality
Standard for NO2 is an arithmetic mean
annual average not to exceed 0.053 ppm
(100 mg/m3). There is a great deal ofdebate
about the necessity for a short-term federal
standard to regulate peak concentrations
over an interval of one or a few hours.
California has a peak hourly standard of
0.25 ppm (470 mg/mi), suggesting an
appropriate short-term standard were the
EPA to take action in this area. Neither the
national nor the California standards as
they currently exist are routinely exceeded,
i.e., most of the outdoor air in the United
States is in conformitywith these standards.
Acute exposure of humans to NO2 at
concentrations above about 150 ppm (282
mg/mi3) causes death, either rapidly due to
pulmonary edema or after a few weeks due
to bronchiolitis obliterans with severe
fibrosis. In animal experiments, exposure of
rats to about 25 ppm (47 mg/m3) for several
days is lethal to more than halfof the ani-
mals. Exposure of rats to concentrations
between about 4 and 20 ppm of NO2 for
several days causes mild edema, increased
protein content of lung lavage fluid,
inflammation, damage to airway epithelial
cells, and bronchiolitis. By these criteria,
there is a NOEL for NO2 in animal experi-
ments at about 2 ppm (30,31).
The effects of chronic exposure of
experimental animals to NO2 have been
relatively less extensively studied than have
been effects of ozone. However, there is
extensive older literature suggesting that
chronic exposure to high concentrations of
NO2 results in emphysema (31-33). More
recent work on the effects ofchronic expo-
sure of specific pathogen-free rats to care-
fully controlled atmospheres has called this
conclusion into question, and has sug-
gested that, like ozone, chronic exposure of
rats to high concentrations of NO2 causes
centriacinar fibrosis (34,35).
NO2 is a far less toxic compound than
ozone in animal experiments (31). On a
molar ratio basis, ozone is about 18 times
more damaging to the lungs of rats than is
NO2, as evaluated histologically (36) or by
more quantitative biochemical measure-
ments (16). It is not immediately obvious
why this disparity in potency is observed as
both ozone and NO2 are highly reactive
oxidants that share the property of proba-
bly being far too reactive to penetrate the
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lung fluid lining layer intact (37). Both
gases are insoluble enough to penetrate to
the deep lung, and both seem to elicit their
major effects in the centriacinar region (38).
One important difference is that ozone dis-
solves in water as ozone, while NO2
probably dissolves in water as its reaction
products in a complex mechanism of reac-
tive uptake (39,40). In addition, unlike
ozone, some NO2 is known to reach the
blood, where it reacts with hemoglobin to
form methemoglobin. In part because ofits
relative insolubility that confers upon it the
ability to reach the alveoli, NO2 has been
suggested, but not shown, to cause emphy-
sema after chronic exposure. Based upon
observations made after accidental expo-
sure ofhumans to lethally high concentra-
tions, NO2 is known to cause bronchiolitis
obliterans and bronchiolar fibrosis (31).
Both NO2 and ozone exposure cause
oxidative stress to the lung, especially in
the small airways and centriacinar regions
where peak doses are received (38). Such
oxidative stress can arise directly from the
high reactivity of these two oxidant gases
and their secondary reaction products with
lung-lining fluids or cell membranes
(37,41). Alternatively, additional oxidative
stress can arise indirectly from superoxide
ion, hydrogen peroxide, and other oxidants
produced by phagocytosis ofcell debris by
inflammatory cells, especially alveolar
macrophages and polymorphonuclear
leukocytes. As discussed by several partici-
pants in this symposium, there are pro-
found effects on the cells of the lung
arising from attack by such oxidants. This
is a complex area ofresearch and details of
specific cellular targets of oxidative stress
and the relevant mechanisms of action are
currently under active study in a large
number oflaboratories (42).
Existing air quality standards for ozone
and NO2 are currently justified by data
from controlled human exposures showing
responses to acute (hours) challenges (in
normal or susceptible subjects) at or near
the level of the standard. These values are
also consistent with NOELs found in ani-
mal experiments using many conventional
toxicologic, biochemical, and histologic
responses to acute exposure regimens
(hours or days). This is perhaps not sur-
prising in that the pulmonary function
tests used to evaluate responses ofhumans
to controlled exposures tend to reflect cel-
lular inflammatory responses in the lung
(43). It is widely believed that the current
standards are protective of human health
based upon acute effects upon human vol-
unteers receiving controlled exposures,
although many people have questioned
whether the current standards for ozone
allow for any margin of safety, much less
the adequate margin of safety that the
Clean Air Act requires (7). On the other
hand, little or no explicit consideration of
potential chronic effects on lung structure
ofexposure to ozone or NO2 has gone into
the setting ofair quality standards, in part
because of the paucity of data available to
guide such a standard-setting exercise. As
the potential for ozone or NO2 to cause
pulmonary fibrosis after chronic exposure
has become more widely appreciated, con-
cern about long-term effects ofchronic low
level exposure to ozone has increased. In
this context, the apparent greater inherent
susceptibility of nonhuman primates to
ozone as compared with rats (44) also
raises concerns, as chronic exposure (20
months) of rats to 0.5 ppm of ozone (or
less) causes pulmonary fibrosis (26).
Mixtures of Ozone and NO2
About 40 years ago Diggle and Gage
(45,46) suggested that mixtures of ozone
and NO2 might react to form nitrogen
pentoxide, N205, that they suggested
might be more toxic than either ozone or
NO2. We have recently reinvestigated the
possibility of interactions between ozone
and NO2 in a series ofstudies encompass-
ing responses of rats to both acute and
chronic exposures. In addition to confirm-
ing the suggestions ofDiggle and Gage, we
have observed several additional responses
ofthe exposed rats that are ofinterest.
Acute exposure of rats to mixtures of
ozone and NO2 elicits a synergistic
response to the mixtures at high dose rates
(47,48). This response was greater than the
sum of the responses to either oxidant gas
alone, and represented true synergy (49).
The exact exposure protocols eliciting this
synergistic interaction varied by assay used,
with differing sensitivities observed when
the end point measured was related to
edema or to cellular inflammatory response.
Many other investigators have exposed lab-
oratory rodents to mixtures of ozone and
NO2 (36,50,51); our experiments differed
in that we used very high ratios ofNO2 to
ozone (18:1) to elicit equal toxic responses
from each ofthe two oxidant gases (16).
Subchronic exposure ofrats to mixtures
of ozone and NO2 results in a syndrome
unlike that elicited by either agent alone.
Relatively low concentrations of the two
gases together (e.g., 0.4 ppm ozone + 7.2
ppm NO2, 12 hr/day, exposure intervals of
about 7 to 10 weeks), cause substantial
numbers ofdeaths in rats (35). Lung colla-
gen content is significantly elevated in rats
exposed for 78 to 90 days to either 0.8
ppm ozone and 14.4 ppm NO2 (6 hr/day),
or to 0.2 ppm ozone and 3.6 ppm NO2
(24 hr/day; the same C x T product in
both regimens). The animals exposed to
0.8 ppm ozone and 14.4 ppm NO2 had
severe pulmonary fibrosis as evaluated his-
tologically, while the animals exposed to
0.2 ppm of ozone and 3.6 ppm NO2 did
not (34). These lesions are apparently irre-
versible, as other groups of rats exposed to
the same C x T product (0.4 ppm ozone
and 7.2 ppm NO2, 12 hr/day; or 0.6 ppm
ozone and 10.8 ppm NO2, 8 hr/day) for
45 days, then allowed to recover in filtered
air for 45 or 60 days, showed continued
accumulation of collagen in their lungs
during the postexposure recovery period.
(Last et al., manuscript in preparation.)
These observations give rise to a new
animal model of progressive pulmonary
fibrosis and to the fascinating question of
what is occurring in the lungs of these rats
over the 6- to 8-week interval before the
damage progresses far enough to kill the
animal. Coupled with these questions is the
observation that total dose of ozone plus
NO2 (as CxT product) is not the critical
determinant of lung injury in this model;
rather, the combination of repetitive expo-
sure periods and recovery periods seems to
be essential for lung damage. To test this
hypothesis we exposed five groups of rats
for 3 days to different CxT products of
ozone and NO2 combined (in multiples of
4.8 ppm/hr and 86.4 ppm/hr, respectively)
at four different total doses. This is a differ-
ent approach from our earlier experiments
(47), where dose rate was varied by deliver-
ing a constant CxT product for different
intervals of time each day. Thus, we
exposed rats for 3 days to nominal concen-
trations of 0.8 ppm ozone plus 14.4 ppm
NO2, and varied the duration of exposure
as follows: group 1, 0 hr/day (controls);
group 2, 6 hr/day; group 3, 12 hr/day;
group 4, 18 hr/day; group 5, 24 hr/day.
Thus, with respect to CxT product,
groups 4 through 1 received 4x, 3x, 2x, and
1x, where x=4.8 ppm/hr + 86.4 ppm/hr of
ozone and NO2, respectively. We would,
therefore, predict that if total dose alone
determines lung damage, we would find
damage in the ratio of 4:3:2:1 in the four
groups of exposed animals. Interestingly,
that is not what we observe. Rather, as
shown in Figure 2, there seems to be a peak
oflung damage in group 3, as evaluated by
assay of the protein content oflung lavage
fluid, despite the fact that group 3 received
only half the total dose (CxT product) as
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Figure 2. Protein content of lung lavage fluid from rats
exposed for 3 days to a mixture of (nominal concentra-
tions) 0.8 ppm ozone + 14.4 ppm NO2 for the indicated
duration of exposure each day. Asterisk indicates a
significant increase above control values (Fisher PLSD
test). Actual concentrations of pollutants were as fol-
lows: group 2 (6 hr/day) 0.84 ± 0.03, 14.0 ± 0.7 ppm;
group 3 (12 hr/day) 0.79 ± 0.04, 14.0 ± 1.1 ppm; group
4 (18 hr/day) 0.86 ± 0.04, 14.4 ± 0.5 ppm; group 5 (24
hr/day) 0.85 ± 0.03, 13.9 ± 0.7 ppm.
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Figure 3. Total lavagable cells from the same rats
exposed for 3 days to the mixture of ozone and N02
detailed in Figure 2.
did group 5 and 3/4 ofthe total dose as did
group 4. The protein content oflavage fluid
in group 3 is significandy higher than that
of groups 2, 4, and 5 (Fisher PLSD test).
All ofthe exposed rats weighed significantly
less than the controls.
We have also examined the cell content
ofthe pellets obtained from the lung lavage
fluid of the same animals (Figures 3,4).
There were significantly more cells in each
ofthe exposure groups than in the controls,
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Figure 4. Differential analysis ofthe cell content in the lavage pelletfrom the rats described in Figures 2 and 3.
and the increased cellularity was inversely
proportional to the duration of exposure.
Thus, groups 2 through 5 had about 475,
380, 200, and 110% increases in cell num-
ber above the control value, respectively.
The total cell numbers were not signifi-
cantlydifferent when groups 2 and 3 (6 and
12 hr/day) were compared, but both of
these groups had significantly greater num-
bers of cells in their lavage fluid than did
the groups 4 and 5 (18 and 24 hr/day) ani-
mals. The increased cell number in these
lavages is due to increases in essentially two
populations: epithelial cells arising from
damage to the airway epithelium, and poly-
morphonuclear leukocytes arising from the
inflammatory response ofthe lung to injury
(Figure 4). Interestingly, neutrophils follow
the same duration-response curve as does
the total cellularity of the lavage fluid:
response is inversely proportional to the
duration of exposure, with groups 2 and 3
not significantly different from each other
but both groups significantly greater than
groups 4 and 5 (Figure 4). Conversely, the
epithelial cell content of the lavage fluid
appears to be directly proportional to the
duration of exposure (Figure 4), with the
higher total C x T product producing more
direct damage to the airwayepithelium.
These observations suggest that, as we
would assume intuitively, the longer the
duration of exposure to the mixture of
ozone and NO2, the greater the effective
dose delivered to the airway epithelium and
the greater the amount ofdirect damage to
the epithelium as evaluated by sloughing of
epithelial cells into the lung-lining layer.
But then something unexpected happens.
Our measurements for whole lung damage,
protein content of lavage fluid supernate,
and total cell content of lavage fluid pellet
(which measure lung edema and inflamma-
tion, respectively) show a very different
pattern of response. The animals exposed
intermittently for 12 hr/day (group 3)
show a significantly greater response than
do those that were exposed to 50 or 100%
more ozone + NO2 (groups 4 and 5,
respectively). Thus, our attention has
begun to focus on the importance of the
recovery period, rather than the exposure
duration, in eliciting lung injury with these
two oxidant gases. Our current working
hypothesis is that repeated episodes of
exposure and recovery (e.g., the regimen
received by group 3 in these experiments)
are more damaging to the lung than is con-
tinuous exposure (i.e., group 5) to the mix-
ture of ozone and NO2. A similar
phenomenon may also occur in lungs of
rats exposed to ozone alone (23,24).
What might be the cause of repeated
intermittent exposures to ozone or to
ozone and NO2 being more damaging to
the lung than continuous exposure to
higher total doses of the pollutants? We
speculate that exhaustion of some essential
antioxidant defense (52) or ofsome essen-
tial precursor cell pool plays a critical role
in the lung's increased susceptibility to
intermittent exposure regimens with alter-
nating cycles ofdamage and repair. This is
a current area ofactive investigation in our
laboratories.
An interesting curiosity that probably
has little real world significance is a syner-
gistic interaction between NO2 and NaCl
aerosol we described several years ago (30).
This interaction almost certainly arises
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from the chemical reaction between NO2
and NaCl to form nitrosyl chloride,
NOCI, the putative toxic agent. This inter-
action, while probably requiring higher
concentrations ofboth reactants than occur
in polluted atmospheres, however high-
lights an important mechanism ofsynergis-
tic interaction when reactive oxidants such
as NO2 are involved, the chemical reaction
ofcomponents ofa mixture to form a new,
more toxic, chemical species. We have
already discussed the interaction of ozone
and NO2 as another example ofthis mech-
anism of synergy. Thus, questions of ade-
quate margins ofsafety for current air qual-
ity standards are also made much more
complicated by the issue ofwhether oxidant
gases may be more toxic as part ofa mixture
than when delivered alone, as is normally
done in controlled exposures to human vol-
unteers or to experimental animals.
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